Latest Valuation News

Aurumin Limited proposes a scheme of arrangement for acquisition by Brightstar Resources, with an independent expert confirming the deal is fair and reasonable. The transaction offers Aurumin shareholders exposure to a larger gold portfolio and enhanced market presence.

Develop Global Limited's updated Definitive Feasibility Study for its Sulphur Springs Zinc-Copper Project reveals a 76% surge in project valuation and a doubling of free cash flow to A$1.5 billion, setting the stage for final investment decision and construction.

Imperial Pacific Limited has announced its Dividend Reinvestment Plan (DRP) issue price for 2025 at $1.85 per new share, maintaining parity with current trading levels and foregoing any discount. New shares will be issued within two weeks, aligning with existing shares.

Hastings Technology Metals has responded to an ASX price query, denying any undisclosed information behind its recent share price and volume spike, citing recent joint venture and asset sale announcements as likely drivers.

BlackWall Limited has confirmed the exact ratio for its in-specie dividend distribution, allocating one WOT security for every 24 BWF shares held as of the record date.

Airtasker has landed a £2.5 million media investment from Channel 4’s venture arm to accelerate growth in the UK, building on a strong marketplace performance and deepening a strategic media partnership.

Solara Minerals has launched a cutting-edge Ultrafine® soil sampling program at its Wilgeena West Project, aiming to pinpoint structural controls of gold mineralisation and generate new drill targets.

Everest Metals Corporation has expanded its Revere Gold Project by acquiring the Armstrong tenement, unveiling promising gold mineralisation ahead of its maiden resource estimate.

Sarama Resources has completed the second tranche of its A$2.6 million equity placement, issuing new options to fund exploration at its Cosmo Gold Project and support arbitration efforts.

Cyclopharm Ltd has been hit with legal proceedings by 4D Medical Limited, accusing it of making false and misleading statements during a March webinar. Cyclopharm denies the allegations, calling the claim without merit.

ActivEX Limited has secured $800,000 through a placement of 50 million shares at a nearly 24% discount, marking a significant capital injection aimed at bolstering its working capital.

Eildon Capital Group has recommended that securityholders accept Samuel Terry Asset Management’s unsolicited $0.875 per security takeover offer, which represents a 24% premium to recent trading prices. An independent expert has deemed the offer fair and reasonable, but uncertainties remain around board composition and liquidity post-offer.